INFORMATION:
The study was funded by a pilot grant from Partners in Research and the National Cancer Institute (R21CA191444 and T32CA009686).
About Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and MedStar Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Georgetown Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute (grant #P30 CA051008), and the only one in the Washington, DC area. For more information, go to http://lombardi.georgetown.edu.
About Georgetown University Medical Center
Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health.
Orphan receptor proteins deliver 2 knock-out punches to glioblastoma cells
2014-12-17
(Press-News.org) WASHINGTON -- Two related proteins exert a lethal double whammy effect against glioblastoma cells when activated with a small molecule, say researchers at Georgetown Lombardi Comprehensive Cancer Center.
The scientists say when activated, one protein, called the short form, stops glioblastoma cells from replicating their DNA, and the other, called the long form, prevents cell division if the DNA has already been replicated, explains Rebecca Riggins, PhD, assistant professor of oncology at Georgetown Lombardi. The study was posted online Dec. 12 in the journal Cell Cycle.
Both proteins are produced by the estrogen-related receptor beta (ERRβ) gene. They are known as "orphan receptors" because they don't bind to any substances naturally produced by the body. ERRβ proteins are similar in shape to the receptor that binds the hormone estrogen -- hence their name -- but they do not bind estrogen and are not otherwise related. Both men and women have ERRβ genes.
In this study, Riggins and her co-author, postdoctoral fellow Mary Heckler, PhD, examined glioblastoma cells in the laboratory for the presence of ERRβ and found both long and short forms. To understand what these proteins were doing, they used a laboratory chemical, DY131, which had been designed to bind and activate these proteins.
To their surprise, the researchers discovered that DY131 exerted a strong, but distinct, effect on both the short and long forms of ERRβ. The short form had been known to act as a tumor suppressor in prostate cancer, and a similar anti-cancer action was found by the researchers in glioblastoma. The study, however, is the first to find a function for the long form in cancer.
"While much work remains to understand the clinical potential of this finding, it may ultimately be possible to directly target the long and short forms of ERRβ in combination with other therapies to improve outcomes in glioblastoma," Riggins says.
Riggins, a member of the breast cancer program at Georgetown Lombardi, is now studying the behavior of the same proteins when activated by DY131 in triple negative breast cancer, for which there is no therapeutic target.
ELSE PRESS RELEASES FROM THIS DATE:
Behavioral analysis of ISIS brutality presented in Violence and Gender journal
2014-12-17
New Rochelle, NY, December 17, 2014-The Sunni Islamist terror organization known as the Islamic State, or ISIS, uses extreme violence and brutality against anyone it perceives as a threat to its goal of expansion and restoration of an Islamic Caliphate. The significant behavioral aspects of this unparalleled violence and its implications for the future are explored in a compelling Review article published in Violence and Gender, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Violence and Gender website at http://online.liebertpub.com/doi/full/10.1089/vio.2014.0037 ...
Genetic variations associated with traits underlying type 2 diabetes in Mexican-Americans
2014-12-17
WINSTON-SALEM, N.C. - Dec. 17, 2014 - While people of Mexican ancestry are nearly twice as likely to develop Type 2 diabetes as people of European heritage, the majority of research in this area has focused on those of European origin.
In an effort to understand why Mexicans are disproportionately affected by the disease, researchers at Wake Forest Baptist Medical Center led the largest study to date to examine the underlying causes. The study is published in the Dec. 17 issue of Diabetes.
"Type 2 diabetes is really about how you dispose of your glucose - how long it ...
Even in restored forests, extreme weather strongly influences wildfire's impacts
2014-12-17
DAVIS, Calif. -- The 2013 Rim Fire, the largest wildland fire ever recorded in the Sierra Nevada region, is still fresh in the minds of Californians, as is the urgent need to bring forests back to a more resilient condition. Land managers are using fire as a tool to mimic past fire conditions, restore fire-dependent forests, and reduce fuels in an effort to lessen the potential for large, high-intensity fires, like the Rim Fire. A study led by the U.S. Forest Service's Pacific Southwest Research Station (PSW) and recently published in the journal Forest Ecology and Management ...
Heat boosts phthalate emissions from vinyl crib mattress covers
2014-12-17
The U.S. continues to look at the use and regulation of phthalates, which have been associated with health problems. Of particular concern is the safety of these plastic additives to children. A new study aims to improve our understanding of one possible exposure route for babies: vinyl crib mattress covers. Scientists report in ACS' Environmental Science & Technology that as these covers warm up, they emit more phthalates into the air.
Ying Xu and Yirui Liang note that previous studies have linked phthalates, which soften plastics, to potential health effects, including ...
New Notre Dame paper offers novel insights into pathogen behavior
2014-12-17
A new study by a team of researchers that includes University of Notre Dame scientists Joshua Shrout and Mark Alber provides new insights into the behavior of an important bacterial pathogen.
Alber, Vincent J. Duncan Family Professor of Applied Mathematics, and Schrout, an associate professor of civil and environmental engineering and earth sciences, studied Pseudomonas aeruginosa, an opportunistic pathogen responsible for both acute and persistent infections.
"While this ubiquitous environmental bacterium rarely infects healthy people, it is a common pathogen among ...
Stroke patients experience superior outcomes with intra-arterial treatment vs. tPA
2014-12-17
ALAMEDA, Calif. - December 17, 2014 - Penumbra, Inc., the market leader in intra-arterial stroke treatment, announced that an independent study published online today in the New England Journal of Medicine found that intra-arterial stroke treatment, including the company's clot extraction technology, was shown to be significantly more effective than medical management with tissue plasminogen activator (tPA), which is the current standard of care. The findings of this randomized, controlled comparative effectiveness trial of stroke treatment have the potential to change ...
New class of synthetic molecules mimics antibodies
2014-12-17
New Haven, Conn. - A Yale University lab has crafted the first synthetic molecules that have both the targeting and response functions of antibodies.
The new molecules -- synthetic antibody mimics (SyAMs) -- attach themselves simultaneously to disease cells and disease-fighting cells. The result is a highly targeted immune response, similar to the action of natural human antibodies.
"Unlike antibodies, however, our molecules are synthetic organic compounds that are approximately one-twentieth the size of antibodies," said David A. Spiegel, a professor of chemistry at ...
A new strategy for developing drugs to fight cancer and other diseases
2014-12-17
Promising treatments known as biologics are on the market and under development for many serious illnesses such as cancer, but some of them come with high risks, even lethal ones. Now scientists have produced a novel class of molecules that could be as effective but without the dangerous side effects. They report their work on these compounds, which they tested on prostate cancer cells, in ACS' Journal of the American Chemical Society.
David A. Spiegel and colleagues explain that biologics are protein-based therapies that have revolutionized cancer treatment over the ...
Guelph researchers recipe: Cook farm waste into energy
2014-12-17
It takes some cooking, but turning farm waste into biofuels is now possible and makes economic sense, according to preliminary research from the University of Guelph.
Guelph researchers are studying how to make biofuels from farm waste, especially "wet" waste that is typically difficult to use. They have developed a fairly simple procedure to transport waste and produce energy from it.
Scientists have struggled to find uses for wet and green waste, including corn husks, tomato vines and manure. Dry farm waste, such as wood chips or sawdust, is easier to use for generating ...
Is the label 'hypoallergenic' helpful or just marketing hype?
2014-12-17
Many consumers seek out shampoos, soaps and cosmetics that are labeled "hypoallergenic" or "dermatologist tested," words that imply the products are safe to use. But recent research gives shoppers reason to question what those labels really mean. Now some scientists and consumer advocates are calling for change, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.
Britt E. Erickson, a senior editor at C&EN, notes that the definitions of the terms "hypoallergenic" and "dermatologist tested/recommended" ...